VSee Health (VSEE) said Monday it expanded its telehealth service offering by launching a new specialized program that will integrate GLP-1 prescription medicines within its existing offerings and is designed to address obesity and related health risks.
The GLP-1 initiative will combine telehealth access, prescription drug support and behavioral intervention, with participants set to receive personalized care plans, virtual support calls and access to GLP-1 medicines. The program provides subscriptions at $4.99 a month, VSee said.
Shares of the company were up 26% in recent Monday premarket activity.
Price: 2.0700, Change: +0.43, Percent Change: +26.22
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。